explore -WSS

explore

author：knowledge 2025-09-28 02:32:29 - browse：73

A pile of Zynex Medical batteries and electrode pads are seen at Michelle Bean's home — A pile of Zynex Medical batteries and electrode pads Kayana Szymczak for STAT

Sending patients heaps of medical supplies to score more money from insurers is common in the device industry. If insurers decline to cover the supplies, patients are stuck paying for materials they didn’t need.

STAT examined one of the companies perpetuating this practice, a pain management device company called Zynex Medical, and the frustration among both its patients and former employees. Here are five takeaways.

The ‘razor blade’ business model

Zynex sells nerve and muscle stimulation machines, known as TENS and EMS units, to treat pain and soothe muscles. But the company makes most of its money from monthly shipments of batteries and electrodes — almost 70% of its $184 million revenue in 2023 came from these supplies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Kaiser's Risant Health gobbled up Geisinger. Who is next?

WSS

HIV drugs protect against transmission, even in unprotected sex

Ohio still needs to do more to protect the right to abortion

With trial win, GSK could get blood cancer drug back on market

Let's speed up science by embracing open access publishing

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

ASCO: Palliative care found as helpful given virtually as in person

knowledge

explore

The ‘razor blade’ business model

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

United colonoscopy coverage change 'may cost lives,' doctors say

Medical school prerequisites are outdated

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A letter from the executive editor: STAT UnitedHealth investigation

Activists slam private health insurers over coverage restrictions

Readout Newsletter: Zepbound, Valneva's vaccine, and more

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Guidelines to prevent youth baseball injuries need more muscle

Ionis drug prevents swelling attacks due to hereditary angioedema

focus

ASCO: Palliative care found as helpful given virtually as in person

How state and local governments are sidelining science

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Medical school prerequisites are outdated

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Wikipedia

entertainment

entertainment

Wikipedia